JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M211090200 on April 22, 2003

J. Biol. Chem., Vol. 278, Issue 31, 29216-29230, August 1, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/31/29216    most recent
M211090200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henkler, F.
Right arrow Articles by Wajant, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henkler, F.
Right arrow Articles by Wajant, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Caspase-mediated Cleavage Converts the Tumor Necrosis Factor (TNF) Receptor-associated Factor (TRAF)-1 from a Selective Modulator of TNF Receptor Signaling to a General Inhibitor of NF-{kappa}B Activation*

Frank Henkler {ddagger}, Bernd Baumann §, Mariola Fotin-Mleczek {ddagger}, Monika Weingärtner {ddagger}, Ralph Schwenzer {ddagger}, Nathalie Peters {ddagger}, Angela Graness {ddagger}, Thomas Wirth §, Peter Scheurich {ddagger}, Johannes A. Schmid ¶ and Harald Wajant {ddagger} ||

From the {ddagger}Institute of Cell Biology and Immunology, University of Stuttgart, Allmandring 31, 70569 Stuttgart, Germany, the §Department of Physiological Chemistry, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, Germany, and the Department of Vascular Biology and Thrombosis Research, University of Vienna, 1235 Vienna, Austria

The role of tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 in NF-{kappa}B activation by various members of the TNF receptor family is not well understood, and conflicting data have been published. Here, we show that TRAF1 differentially affects TRAF2 recruitment and activation of NF-{kappa}B by members of the TNF receptor family. Interestingly, a naturally occurring caspase-derived cleavage product of TRAF1 solely comprising its TRAF domain (TRAF1-(164–416)) acted as a general inhibitor of NF-{kappa}B activation. In contrast, a corresponding fragment generated by cleavage of TRAF3 showed no effect in this regard. In accordance with these functional data, TRAF1, but not TRAF3, interacted with the IKK complex via its N-TRAF domain. Endogenous TRAF1 and the overexpressed TRAF domain of TRAF1 were found to be constitutively associated with the IKK complex, whereas endogenous receptor interacting protein was only transiently associated with the IKK complex upon TNF stimulation. Importantly, the caspase-generated TRAF1-fragment, but not TRAF1 itself inhibited IKK activation. Our results suggest that TRAF1 and TRAF1-(164–416) exert their regulatory effects on receptor-induced NF-{kappa}B activation not only by modulation of TRAF2 receptor interaction but especially TRAF1-(164–416) also by directly targeting the IKK complex.


Received for publication, October 30, 2002 , and in revised form, March 17, 2003.

* This work was supported by Deutsche Forschungsgemeinschaft Grants Wa 1025/3-1, SFB 495/A5, and SFB 497/B1. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Dept. of Molecular Internal Medicine, Medical Polyclinic, University of Wuerzburg, Roentgenring 11, 97070 Wuerzburg, Germany. Tel.: 49-931-201-71000; Fax: 49-931-201-71070; E-mail: harald.wajant{at}mail.uni-wuerzburg.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
M. Baumel, A. Lechner, T. Hehlgans, and D. N. Mannel
Enhanced susceptibility to Con A-induced liver injury in mice transgenic for the intracellular isoform of human TNF receptor type 2
J. Leukoc. Biol., July 1, 2008; 84(1): 162 - 169.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Sabbagh, G. Pulle, Y. Liu, E. N. Tsitsikov, and T. H. Watts
ERK-Dependent Bim Modulation Downstream of the 4-1BB-TRAF1 Signaling Axis Is a Critical Mediator of CD8 T Cell Survival In Vivo
J. Immunol., June 15, 2008; 180(12): 8093 - 8101.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. K. Oyoshi, P. Bryce, S. Goya, M. Pichavant, D. T. Umetsu, H. C. Oettgen, and E. N. Tsitsikov
TNF Receptor-Associated Factor 1 Expressed in Resident Lung Cells Is Required for the Development of Allergic Lung Inflammation
J. Immunol., February 1, 2008; 180(3): 1878 - 1885.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Sabbagh, C. C. Srokowski, G. Pulle, L. M. Snell, B. J. Sedgmen, Y. Liu, E. N. Tsitsikov, and T. H. Watts
A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival
PNAS, December 5, 2006; 103(49): 18703 - 18708.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Xie, B. S. Hostager, M. E. Munroe, C. R. Moore, and G. A. Bishop
Cooperation between TNF Receptor-Associated Factors 1 and 2 in CD40 Signaling
J. Immunol., May 1, 2006; 176(9): 5388 - 5400.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
P. J. Bryce, M. K. Oyoshi, S. Kawamoto, H. C. Oettgen, and E. N. Tsitsikov
TRAF1 regulates Th2 differentiation, allergic inflammation and nuclear localization of the Th2 transcription factor, NIP45
Int. Immunol., January 1, 2006; 18(1): 101 - 111.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Y. Ma, S. A. Mikolajczak, A. Danesh, K. A. Hosiawa, C. M. Cameron, A. Takaori-Kondo, T. Uchiyama, D. J. Kelvin, and A. Ochi
The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells
Blood, September 15, 2005; 106(6): 2002 - 2010.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. S. Pryhuber, H. L. Huyck, J. M. Roper, J. Cornejo, M. A. O'Reilly, R. H. Pierce, and E. N. Tsitsikov
Acute Tumor Necrosis Factor-{alpha}-Induced Liver Injury in the Absence of Tumor Necrosis Factor Receptor-Associated Factor 1 Gene Expression
Am. J. Pathol., June 1, 2005; 166(6): 1637 - 1645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Fotin-Mleczek, F. Henkler, A. Hausser, H. Glauner, D. Samel, A. Graness, P. Scheurich, D. Mauri, and H. Wajant
Tumor Necrosis Factor Receptor-associated Factor (TRAF) 1 Regulates CD40-induced TRAF2-mediated NF-{kappa}B Activation
J. Biol. Chem., January 2, 2004; 279(1): 677 - 685.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.